Next Article in Journal
Cytokine and Chemokine Production in Mice Inoculated with NVX-CoV2373 (Nuvaxovid®) in Comparison with Omicron BA.4/5 Bivalent BNT162b2 (Comirnaty®)
Next Article in Special Issue
Comparative Analysis of Primary and Monovalent Booster SARS-CoV-2 Vaccination Coverage in Adults with and without HIV in Catalonia, Spain
Previous Article in Journal
Self−Assembling Nanovaccine Fused with Flagellin Enhances Protective Effect against Foot−and−Mouth Disease Virus
Previous Article in Special Issue
COVID-19 Risk Perception and Adherence to Preventive Measures among Medical Students after Receiving COVID-19 Vaccination: A Multicenter Cross-Sectional Study in Egypt
 
 
Article

Article Versions Notes

Vaccines 2023, 11(11), 1676; https://doi.org/10.3390/vaccines11111676
Action Date Notes Link
article xml file uploaded 2 November 2023 08:24 CET Original file -
article xml uploaded. 2 November 2023 08:24 CET Update https://www.mdpi.com/2076-393X/11/11/1676/xml
article pdf uploaded. 2 November 2023 08:24 CET Version of Record https://www.mdpi.com/2076-393X/11/11/1676/pdf
article supplementary file uploaded. 2 November 2023 08:24 CET - https://www.mdpi.com/2076-393X/11/11/1676#supplementary
article html file updated 2 November 2023 08:26 CET Original file https://www.mdpi.com/2076-393X/11/11/1676/html
Back to TopTop